RESEARCH
Home Introduction Divisions Organized Research Units Research Training Program Selected Scholarly Interests

Patricia W. Finn, MD. Department Chair

© Copyright 2014 The Board of Trustees of the University of Illinois

    James P. Lash, M.D.


Academic Title Professor of Medicine                                                                                        

Administrative Positions:

Division: Nephrology

Location: 820 S. Wood St., 416W CSN (MC 793), Chicago, IL 60612

Phone: (312)996-6736 (Office) Fax: (312)355-3992

E-mail: jplash@uic.edu





Education:

MD, University of Chicago Pritzker School of Medicine, Chicago, IL (1981)

Intern, Michael Reese Hospital and Medical Center, Chicago, IL (1981-1982)

Resident, Michael Reese Hospital and Medical Center, Chicago, IL (1982-1984)

Fellow, Chicago Medical School, North Chicago, Chicago, IL (1989-1991)


Faculty Positions:


Clinical Specialties


Research Interests


Selected Publications

  1. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, Cheek D, Cleveland W, Douglas JG, Douglas M, Dowie D, Faulkner, M, Gabriel A, Gassman J, Greene T, Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M, Massry S, Middleton J, Miller ER 3rd, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr and Xu S.  Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.  JAMA 285(21):2719-28, 2001.
  2. Lash JP, Wang X, Greene T, Gadegbeku CA, Hall Y, Jones K, Kusek JW, Sika M and Unruh M. Quality of Life in African Americans with Hypertensive Kidney Disease:  Effects of Blood Pressure Management. Am. J. Kidney Dis. 47:956-64, 2006.
  3. Peralta CA, Shlipak MG, Fan D, Ordoñez J, Lash JP, Chertow GM and Go AS. Risks of end-stage renal disease, cardiovascular events, and death in Hispanics versus non-Hispanic whites with chronic kidney disease. J. Am. Soc. Nephrol. 17:2892, 2006.
  4. Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, Townsend RR, Xie D, Cifelli D, Cohan J, Fink JC, Fischer MJ, Gadegbeku C, Hamm LL, Kusek JW, Landis JR, Narva A, Robinson N, Teal V and Feldman HI. The Chronic Renal Insufficiency Cohort (CRIC) Study: Baseline Characteristics and Associations with Kidney Function. Clin. J. Am. Soc. Nephrol. 4(8):1302-11, 2009.
  5. Ricardo AC, Fischer MJ, Peck A, Turyk M and Lash JP.  Depressive symptoms and chronic kidney disease: Results from the National Health and Nutrition Examination Survey (NHANES) 2005-2006.  Int. J. Urol. Nephrol. 42:1063-8, 2010.
  6. Appel LJ, Wright JT, Greene T, Agodoa LY, Astor BC, Bakris G, Cleveland W, Charleston J, Contreras G, Faulkner ML, Gabbai FB, Gassman J, Hevert LA, Jamerson K, Kopple J, Kussek JW, Lash JP, Lea JP, Lewis JB, Lipkowitz M, Massry SG, Miller ER, Norris K, Phillips RA, Pogue VA, Randall OS, Rostand SG, Smogorzewski M, Toto RD and Wang X. Intensive blood-pressure control in hypertensive chronic kidney disease. N. Engl. J. Med. 363:918-29, 2010.
  7. Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutiérrez OM, Steigerwalt S, He J, Schwartz S, Lo J, Ojo A, Sondheimer J, Hsu CY, Lash J, Leonard M, Kusek JW, Feldman HI and Wolf M. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 305:2432-9, 2011.
  8. Fischer MJ, Kimmel PL, Greene T, Gassman J, Wang X, Brooks D, Charleston J, Dowie D, Thornley-Brown D, Cooper LA, Bruce MA, Kusek JW, Norris K and Lash JP. Depressive affect and the risk of cardiovascular events, end-stage renal disease, hospitalization, and death among African Americans with chronic kidney disease. Kidney Int. 80(6):670-8, 2011.
  9. Ricardo AC, Lash JP, Fischer MJ, Lora CM, Budoff M, Keane MG, Kusek JW, Martinez M, Nessel L, Stamos T, Ojo A, Rahman M, Soliman EZ, Yang W, Feldman HI and Go AS. Disease among Hispanics and non-Hispanics in the Chronic Renal Insufficiency Cohort (CRIC) Study. Clin. J. Am. Soc. Nephrol. 6:2121-31, 2011. PMID:  21896829
  10. Fischer MJ, Go A, Lora C, Ackerson L, Cohan J, Kusek J, Mercado A, Ojo A, Ricardo AC, Rosen L, Tao K, Xie D, Feldman HI and Lash J.  Chronic kidney disease in Hispanics: Baseline characteristics of the Hispanic Chronic Renal Insufficiency Cohort Study.  Am. J. Kidney Dis. 58:214-27, 2011.
  11. Fischer MJ, Xie D, Jordan N, Kop WJ, Krousel-Wood M, Kurella Tamura M, Kusek JW, Ford V, Rosen LK, Strauss L, Teal VL, Yaffe K, Powe NR and Lash JP. Factors Associated with Depressive Symptoms and Use of Antidepressant Medications among Participants in the Chronic Renal Insufficiency Cohort (CRIC) and Hispanic-CRIC Studies. Am. J. Kidney Dis. 60:27-38 , 2012.
  12. Lora CM, Ricardo AC, Brecklin, CS, Fischer, MJ, Rosman RT, Carmona E, Lopez A, Balaram M, Nessel L, Tao K, Xie D, Kusek  JW, Go AS, Lash JP. Recruitment of Hispanics into an observational study of chronic kidney disease: The Hispanic Chronic Renal Insufficiency Cohort Study experience. Contemp. Clin. Trials. 33:1238-44, 2012.